Clinical Trials Insight: 700043202

Trial Profile

Clinical Trials Insight: 700043202

Planning
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 08 Apr 2009

At a glance

  • Drugs Iguratimod (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors Eisai Co Ltd; Toyama Chemical
  • Most Recent Events

    • 08 Apr 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top